Bayer AG’s profit unexpectedly rose in the second quarter, helped by strong demand for soybean seeds and weedkillers at its crop science division.
The phase 2 study A Phase 2, Randomized, Open-label Study of VVD-133214 in Combination With Pembrolizumab Compared to Pembrolizumab Monotherapy tests a new approach for advanced colorectal cancer with ...
Bayer stock trades around 48.6 euros on Xetra on September 18, 2026, about 9 percent below its 52-week high after a strong ...
Bayer operates three main divisions that together form an integrated life-science portfolio. The pharmaceutical unit focuses on prescription medicines in areas such as cardiology, oncology and women’s ...
Bayer AG S/ADR by Bayer AG BAYRY shares are jumping on Thursday. The U.S. Supreme Court delivered a major legal win for the company in long‑running Roundup litigation. Here’s what you need to know.
Bayer AG (BAYN.DE,BYR.L) on Thursday announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for HYRNUO (sevabertinib) as the first-line treatment for adult ...
Viralgen is a subsidiary of AskBio Inc., which itself operates under Bayer AG (BYR.L). The partnership aims to accelerate the production of EPY201, EpilepsyGTx's lead investigational program for focal ...
Bayer said on Wednesday its Crop Science business had introduced two out of 10 planned new products with peak annual sales of at least €500 million each and mapped out further market launches.
Check out the latest Bayer Ag (BAYRY) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.
Editor's Note: This news release was submitted by Bayer and is published here in its entirety. Bayer is implementing its previously announced ambition to bring 10 blockbusters to market over 10 years, ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The US Supreme Court shielded Bayer AG from tens of thousands of claims that its Roundup herbicide should have been labeled as a cancer risk in a ruling that will help end a decade-long flood of ...